News Daily News Patients With Schizophrenia Reap Gains From CV Meds After MI Todd Neale October 24, 2018
News Daily News Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected Todd Neale October 15, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD Shelley Wood September 26, 2018
News Conference News ESC 2018 Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated Todd Neale September 04, 2018
News Daily News Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’ Michael O'Riordan August 21, 2018
News Daily News New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients Michael O'Riordan August 13, 2018
News Daily News Peer Pressure May Push Physicians to Do Better at Prescribing Statins Lucy Hicks July 30, 2018
News Daily News Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease Michael O'Riordan June 07, 2018
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018
News Daily News Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials Todd Neale February 06, 2018
News Features Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives Yael L. Maxwell January 12, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US Yael L. Maxwell December 07, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017